NAGE
Income statement / Annual
Last year (2025), Niagen Bioscience Inc.'s total revenue was $129.42 M,
an increase of 29.95% from the previous year.
In 2025, Niagen Bioscience Inc.'s net income was $17.38 M.
See Niagen Bioscience Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$129.42 M |
$99.60 M |
$83.57 M |
$72.05 M |
$67.45 M |
$59.26 M |
$46.29 M |
$31.56 M |
$21.20 M |
$21.66 M |
| Cost of Revenue |
$46.23 M
|
$38.01 M
|
$32.79 M
|
$29.25 M
|
$25.96 M
|
$23.98 M
|
$20.52 M
|
$15.50 M
|
$10.72 M
|
$11.27 M
|
| Gross Profit |
$83.19 M
|
$61.59 M
|
$50.78 M
|
$42.80 M
|
$41.49 M
|
$35.27 M
|
$25.77 M
|
$16.06 M
|
$10.48 M
|
$10.39 M
|
| Gross Profit Ratio |
0.64
|
0.62
|
0.61
|
0.59
|
0.62
|
0.6
|
0.56
|
0.51
|
0.49
|
0.48
|
| Research and Development Expenses |
$6.33 M
|
$6.02 M
|
$4.96 M
|
$4.83 M
|
$3.83 M
|
$3.42 M
|
$4.42 M
|
$5.48 M
|
$4.01 M
|
$2.52 M
|
| General & Administrative Expenses |
$27.06 M
|
$18.38 M
|
$24.98 M
|
$28.29 M
|
$36.38 M
|
$30.77 M
|
$34.31 M
|
$27.14 M
|
$17.64 M
|
$9.21 M
|
| Selling & Marketing Expenses |
$35.51 M
|
$29.47 M
|
$26.44 M
|
$28.31 M
|
$28.35 M
|
$20.95 M
|
$18.22 M
|
$16.54 M
|
$4.46 M
|
$1.56 M
|
| Selling, General & Administrative Expenses |
$62.56 M
|
$47.84 M
|
$51.42 M
|
$56.60 M
|
$64.73 M
|
$51.71 M
|
$52.52 M
|
$43.67 M
|
$22.10 M
|
$10.77 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$125.00 K
|
$75.00 K
|
$746.00 K
|
$0.00
|
| Operating Expenses |
$68.89 M
|
$53.86 M
|
$56.38 M
|
$61.43 M
|
$68.56 M
|
$55.13 M
|
$57.07 M
|
$49.23 M
|
$26.85 M
|
$13.30 M
|
| Cost And Expenses |
$115.13 M
|
$91.87 M
|
$89.17 M
|
$90.68 M
|
$94.52 M
|
$79.11 M
|
$77.59 M
|
$64.73 M
|
$37.58 M
|
$24.57 M
|
| Interest Income |
$2.13 M
|
$1.13 M
|
$661.00 K
|
$3.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$2.25 K
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$55.00 K
|
$71.00 K
|
$847.00 K
|
$79.00 K
|
$153.00 K
|
$371.90 K
|
| Depreciation & Amortization |
$1.45 M
|
$1.48 M
|
$1.71 M
|
$1.88 M
|
$1.63 M
|
$1.51 M
|
$1.52 M
|
$842.00 K
|
$716.00 K
|
$419.56 K
|
| EBITDA |
$19.64 M |
$10.34 M |
-$3.23 M |
-$14.66 M |
-$25.45 M |
-$18.34 M |
-$29.78 M |
-$32.33 M |
-$15.66 M |
-$2.49 M |
| EBITDA Ratio |
0.15
|
0.1
|
-0.04
|
-0.2
|
-0.38
|
-0.31
|
-0.64
|
-1.02
|
-0.74
|
-0.11
|
| Operating Income Ratio |
0.11
|
0.08
|
-0.07
|
-0.26
|
-0.4
|
-0.34
|
-0.68
|
-1.05
|
-0.77
|
-0.13
|
| Total Other Income/Expenses Net |
$3.90 M
|
$1.13 M
|
$661.00 K
|
$2.09 M
|
-$55.00 K
|
-$71.00 K
|
-$847.00 K
|
-$144.00 K
|
-$153.00 K
|
-$646.39 K
|
| Income Before Tax |
$18.19 M
|
$8.86 M
|
-$4.94 M
|
-$16.54 M
|
-$27.13 M
|
-$19.93 M
|
-$32.15 M
|
-$33.32 M
|
-$16.53 M
|
-$3.55 M
|
| Income Before Tax Ratio |
0.14
|
0.09
|
-0.06
|
-0.23
|
-0.4
|
-0.34
|
-0.69
|
-1.06
|
-0.78
|
-0.16
|
| Income Tax Expense |
$810.00 K
|
$305.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
$17.38 M
|
$8.55 M
|
-$4.94 M
|
-$16.54 M
|
-$27.13 M
|
-$19.93 M
|
-$32.15 M
|
-$33.32 M
|
-$11.38 M
|
-$2.93 M
|
| Net Income Ratio |
0.13
|
0.09
|
-0.06
|
-0.23
|
-0.4
|
-0.34
|
-0.69
|
-1.06
|
-0.54
|
-0.14
|
| EPS |
0.22 |
0.1 |
-0.07 |
-0.24 |
-0.4 |
-0.33 |
-0.56 |
-0.61 |
-0.26 |
-0.0785 |
| EPS Diluted |
0.2 |
0.11 |
-0.0659 |
-0.24 |
-0.4 |
-0.33 |
-0.56 |
-0.61 |
-0.26 |
-0.0785 |
| Weighted Average Shares Out |
$79.18 M
|
$85.42 M
|
$70.54 M
|
$68.92 M
|
$67.19 M
|
$61.07 M
|
$57.06 M
|
$55.01 M
|
$44.60 M
|
$37.29 M
|
| Weighted Average Shares Out Diluted |
$85.44 M
|
$79.72 M
|
$74.99 M
|
$69.73 M
|
$67.19 M
|
$61.07 M
|
$57.06 M
|
$55.01 M
|
$44.60 M
|
$37.29 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
